First Quadrant’s Otonomy, Inc. OTIC Stock Holding History

First Quadrant’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14,639	Closed	-$95K	–	627
2020 Q4	$95K	Buy	+14,639	New	+$66.5K	0.01%	429

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

First Quadrant's OTIC Position: Q1 2021 in Review

First Quadrant sold out of Otonomy, Inc. (OTIC) in Q1 2021, closing a stake of 14,639 shares — an estimated $95K sold.

First Quadrant first reported a position in OTIC in Q4 2020 and held it in 1 quarter. The position peaked at $95K in Q4 2020. 62 funds tracked by Wall St. Rank hold OTIC as of Q1 2021.

First Quadrant reported no remaining Otonomy, Inc. position as of Q1 2021 after selling out during the quarter.
First Quadrant sold 14,639 Otonomy, Inc. shares in Q1 2021, an estimated $95K.
First Quadrant first reported a position in Otonomy, Inc. in Q4 2020 and held it in 1 quarter.
First Quadrant's Otonomy, Inc. position peaked at $95K in Q4 2020.
62 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q1 2021.

Based on First Quadrant's 13F filing for Q1 2021, filed 27 Apr 2021.